IRadimed Corporation
IRMD
$92.50
$1.291.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -6.88% | -3.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.88% | -3.14% | |||
| Cost of Revenue | 2.73% | -8.75% | |||
| Gross Profit | -9.84% | -1.28% | |||
| SG&A Expenses | -5.90% | -5.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.52% | -5.49% | |||
| Operating Income | -11.69% | 2.02% | |||
| Income Before Tax | -11.34% | -0.28% | |||
| Income Tax Expenses | -14.40% | 44.67% | |||
| Earnings from Continuing Operations | -10.31% | -9.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.31% | -9.69% | |||
| EBIT | -11.69% | 2.02% | |||
| EBITDA | -11.58% | 2.91% | |||
| EPS Basic | -10.31% | -10.01% | |||
| Normalized Basic EPS | -11.37% | 2.04% | |||
| EPS Diluted | -9.29% | -10.05% | |||
| Normalized Diluted EPS | -11.37% | 2.44% | |||
| Average Basic Shares Outstanding | 0.01% | 0.35% | |||
| Average Diluted Shares Outstanding | 0.02% | -0.04% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.12% | -0.67% | |||